Atlas Trials

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

Clinical trial NCT02366208 · COMPLETED

Trial details

NCT number
NCT02366208
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2011-05-01
Primary completion
2013-06-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.